Skip to main content
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1987 Sep;44(9):633–637. doi: 10.1136/oem.44.9.633

IgM antibody production in mice intraperitoneally injected with zirconium oxychloride.

S Shima 1, K Morita 1, S Tachikawa 1, T Ito 1, H Kurita 1, T Yoshida 1, Y Kato 1, Y Yamamoto 1
PMCID: PMC1007889  PMID: 3663528

Abstract

The effect of zirconium (Zr) on the humoral immune response was studied by measuring the level of IgM-plaque forming cells (IgM-PFC) against sheep red blood cells (SRBC) in the spleen of C57 BL mice intraperitoneally injected with zirconium oxychloride. Two experiments, a single injection of zirconium oxychloride of 1/5, 1/10, 1/50, and 1/100 of the LD50 for intraperitoneal injection and continuous injection of 1/20, 1/40, and 1/80 of the LD50 every other day for two or four weeks in mice, were carried out. In the case of a single injection zirconium oxychloride was intraperitoneally injected on days -1, 0, +1, +2, and +3 in relation to SRBC immunisation. The following conclusions may be drawn from this study: (1) Zr was shown to have an adjuvant like activity in relation to the humoral immune response, at least to IgM antibody production; (2) this effect was recognised not only with a single injection with Zr but also after continuous injection; (3) a single injection of Zr was more effective when the mice were treated with Zr 24 hours before or after SRBC immunisation; and (4) with regard to an injected dose of Zr, it was shown that a lower dose (1/50, 1/100 of the LD50 for a single injection and 1/40, 1/80 of the LD50 for continuous injection) led to a more enhanced level of IgM-PFC than a higher dose (1/5, 1/10 of the LD50 for a single injection, and 1/20 of the LD50 for continuous injection).

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN J. R., MASTROMATTEO E., HORWOOD J. Zirconium lactate and barium zirconate. Acute toxicity and inhalation effects in experimental animals. Am Ind Hyg Assoc J. 1963 Mar-Apr;24:131–136. doi: 10.1080/00028896309342940. [DOI] [PubMed] [Google Scholar]
  2. Cleare M. J., Hughes E. G., Jacoby B., Pepys J. Immediate (type I) allergic responses to platinum compounds. Clin Allergy. 1976 Mar;6(2):183–195. doi: 10.1111/j.1365-2222.1976.tb01897.x. [DOI] [PubMed] [Google Scholar]
  3. Cunningham A. J. A method of increased sensitivity for detecting single antibody-forming cells. Nature. 1965 Sep 4;207(5001):1106–1107. doi: 10.1038/2071106a0. [DOI] [PubMed] [Google Scholar]
  4. Kang K. Y., Bice D., Salvaggio J. Delayed hypersensitivity study on zirconium compounds and beryllium sulfate. Med J Osaka Univ. 1976 Mar;26(3-4):131–145. [PubMed] [Google Scholar]
  5. PRIOR J. T., CRONK G. A., ZIEGLER D. D. Pathological changes associated with the inhalation of sodium zirconium lactate. Arch Environ Health. 1960 Oct;1:297–300. doi: 10.1080/00039896.1960.10662700. [DOI] [PubMed] [Google Scholar]
  6. REED C. E. A study of the effects on the lung of industrial exposure to zirconium dusts. AMA Arch Ind Health. 1956 Jun;13(6):578–580. [PubMed] [Google Scholar]
  7. Shima S., Morita K., Murai Y., Taniwaki H., Yamamoto Y., Inoue S. [The adjuvant activity of beryllium]. Nihon Eiseigaku Zasshi. 1985 Dec;40(5):849–854. doi: 10.1265/jjh.40.849. [DOI] [PubMed] [Google Scholar]
  8. Spiegelberg T., Kördel W., Hochrainer D. Effects of NiO inhalation on alveolar macrophages and the humoral immune systems of rats. Ecotoxicol Environ Saf. 1984 Dec;8(6):516–525. doi: 10.1016/0147-6513(84)90011-3. [DOI] [PubMed] [Google Scholar]
  9. Yahara I., Edelman G. M. Restriction of the mobility of lymphocyte immunoglobulin receptors by concanavalin A. Proc Natl Acad Sci U S A. 1972 Mar;69(3):608–612. doi: 10.1073/pnas.69.3.608. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES